Dental Care Clinics in New Providence, NJ Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Singh And Smile Pediatric Dentistry Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 180 South St Ste 104, New Providence, NJ 07974 Phone: 908-312-7300 |
New Providence Dentistry Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 571 Central Ave Ste 100, New Providence, NJ 07974 Phone: 908-376-9297 |
Dear Dental Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 890 Mountain Ave Ste 310, New Providence, NJ 07974 Phone: 551-222-0072 |
Henry The Dentist 1 New Jersey P.a. Dentist Medicare: Not Enrolled in Medicare Practice Location: 890 Mountain Ave Ste 310, New Providence, NJ 07974 Phone: 551-999-2226 Fax: 908-926-2636 |
Carlos Moglianesi, D.m.d. Pc Dentist - Prosthodontics Medicare: Not Enrolled in Medicare Practice Location: 1806 Springfield Ave., New Providence, NJ 07974 Phone: 908-665-2300 Fax: 908-665-9200 |
Violet Dental Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 890 Mountain Ave, New Providence, NJ 07974 Phone: 949-305-2253 |
Terrana Orthodontics Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 65 South St Fl 2, New Providence, NJ 07974 Phone: 908-838-9220 |
News Archive
First computerized genome-scale model of cancer cell metabolism
Scientists are constantly on the hunt for treatments that can selectively target cancer cells, leaving other cells in our bodies unharmed.
Study provides new insights into molecular basis of CaSR-related human diseases
A study led by researchers at Georgia State University provides new insights into the molecular basis of human diseases resulting from mutations in the calcium-sensing receptor (CaSR), a protein found in cell membranes.
Congress of CA Seniors' seminar to focus on elder abuse
Finding ways to end elder abuse is the theme of a free seminar sponsored by the Congress of California Seniors Region 3. The event will be held from 11:30 a.m.-2 p.m. on Thursday, May 17, 2012 at the St. Regis Retirement Center, 23950 Mission Blvd., in Hayward.
Intellect Neurosciences receives U.S. patent allowance for ANTISENILIN to treat AD
Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases announced today that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent claims covering the company's ANTISENILIN monoclonal antibody platform technology for the treatment and prevention of Alzheimer's disease.
Infinity Pharmaceuticals to present IPI-926 inhibitor Phase 1 data at ESMO Congress
Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.
› Verified 4 days ago